Showing results (171-180 of 490) with videos related to
Sort By:
Pageof 49
Pharmaceutical Research|July 28, 2001
Altered disposition and effect of lerisetron in rats with elevated alpha 1-acid glycoprotein levelsN Jauregizar, R Calvo, E Suarez, et al.Endocrinology|March 1, 1997
Maternal nonthyroidal illness and fetal thyroid hormone status, as studied in the streptozotocin-induced diabetes mellitus rat modelR Calvo, G Morreale de Escobar, F Escobar del Rey, et al.Transfusion|October 10, 2012
Measurement of the absolute immature platelet number reflects marrow production and is not impacted by platelet transfusionTaha Bat, Susan F Leitman, Katherine R Calvo, et al.Nutricion Hospitalaria|November 2, 2012
[Training model for integral treatment of patients with eating disorders resistant to change]R Calvo Sagardoy, L T Gallego Morales, A García de Lorenzo y MateosJournal of Chromatography. B, Biomedical Sciences and Applications|April 15, 1999
Simultaneous determination of tramadol and its major active metabolite O-demethyltramadol by high-performance liquid chromatography with electrochemical detectionM Valle, J M Pavón, R Calvo, et al.Thyroid : Official Journal of the American Thyroid Association|February 1, 1997
Maternal diabetes mellitus, a rat model for nonthyroidal illness: correction of hypothyroxinemia with thyroxine treatment does not improve fetal thyroid hormone statusR Calvo, G Morreale de Escobar, F Escobar del Rey, et al.Revista Espanola De Medicina Nuclear|September 11, 1999
[Use of a cyclotron in the production of positron emitting radionuclides]J Martí-Climent, I Peñuelas, R Calvo, et al.The Journal of Pharmacology and Experimental Therapeutics|April 25, 2000
Pharmacokinetic-pharmacodynamic modeling of the antinociceptive effects of main active metabolites of tramadol, (+)-O-desmethyltramadol and (-)-O-desmethyltramadol, in ratsM Valle, M J Garrido, J M Pavón, et al.Seminars in Hematology|December 22, 2018
The challenging task of enumerating blasts in the bone marrowAaron Hodes, Katherine R Calvo, Alina Dulau, et al.Biotechnology Therapeutics|January 1, 1993
Characterization of melatonin binding sites in human peripheral blood neutrophilsM A Lopez-Gonzalez, J R Calvo, J J Segura, et al.Pageof 49